Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Comments Off on Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
April 27, 2026
This systematic review evaluates the efficacy and safety of cannabinoids for neuropsychiatric symptoms in dementia. Neuropsychiatric symptoms are common in dementia and pose significant challenges. Cannabinoids offer a promising treatment option for…
Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
Comments Off on Efficacy and Safety of Cannabinoids for Neuropsychiatric Symptoms of Dementia: A Systematic Review with Meta-analysis.
April 21, 2026
This systematic review evaluates cannabinoid efficacy dementia symptoms including agitation, anxiety, and depression in patients with dementia. It highlights cannabinoids as a potential safer alternative to traditional antipsychotics. The study…
Three Preliminary Studies on Cannabis, Social Isolation, and Dementia
Comments Off on Three Preliminary Studies on Cannabis, Social Isolation, and Dementia
March 26, 2026
Geriatric psychiatry cannabis research reveals early signals but no firm conclusions on cannabinoids' effects in older adults. Studies highlight social isolation and dementia contexts. Controlled evidence remains insufficient for clinical guidance.